drugset / Trial / NCT02618876

Effect of Caudal Nalbuphine on Postoperative Analgesia in Children

NCT02618876

Completed 60 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Nalbuphine as an adjuvant to bupivacaine caudal anesthesia for postoperative analgesia in children undergoing Hypospadias repair. 2 groups, 30 patients each

Timeline

Start
2015-11
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nalbuphine Small molecule
Background Bupivacaine Other / unclassified

Indications

No indication recorded.